Disclosed herein are methods of treating a condition affecting nerve tissue, skin tissue, organ tissue, or vascular tissue using a placenta-derived composition comprising placental tissue and one or more protease inhibitors. Also disclosed herein are methods of treating an individual having a malady comprising a traumatic brain injury or a neurological degenerative disease such as Alzheimer's disease, Parkinson's disease, or Amyotrophic lateral sclerosis (ALS) with a placenta-derived composition.
Disclosed herein are methods of treating a condition affecting bone tissue, muscle tissue, or connective tissue using a placenta-derived composition comprising placental tissue and one or more protease inhibitors. Also disclosed herein are methods of treating an individual having a malady comprising arthritis, osteoporosis, or fibrosis with a placenta-derived composition. Further disclosed herein are methods of treating an individual having irradiation damage to bone, muscle, or connective tissue with a placenta-derived composition.
Compositions and associated methods of preparing placental tissue products/compositions are disclosed together with methods of utilizing the placental tissue composition for delivery of a therapeutic agent.
A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
Disclosed herein are methods of treating a condition affecting bone tissue, muscle tissue, or connective tissue using a placenta-derived composition comprising placental tissue and one or more protease inhibitors. Also disclosed herein are methods of treating an individual having a malady comprising arthritis, osteoporosis, or fibrosis with a placenta-derived composition. Further disclosed herein are methods of treating an individual having irradiation damage to bone, muscle, or connective tissue with a placenta-derived composition.
Disclosed herein are methods of treating a condition affecting nerve tissue, skin tissue, organ tissue, or vascular tissue using a placenta-derived composition comprising placental tissue and one or more protease inhibitors. Also disclosed herein are methods of treating an individual having a malady comprising a traumatic brain injury or a neurological degenerative disease such as Alzheimer's disease, Parkinson's disease, or Amyotrophic lateral sclerosis (ALS) with a placenta-derived composition.
A liquid formulation comprising an acellular extract of placental tissue and a solvent that may prevent the onset or reduce the symptoms of an intestinal condition in a subject when a therapeutically effective amount of the liquid formulation is delivered to a gastric system of the subject.
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
A61K 31/145 - Amines, p. ex. amantadine ayant des atomes de soufre, p. ex. thiurames (N-C(S)-S-C(S)-N ou N-C(S)-S-S-C(S)-N)Sulfinylamines (-N=SO)Sulfonylamines (-N=SO2)
A61K 38/57 - Inhibiteurs de protéases provenant d'animauxInhibiteurs de protéases provenant d'humains
A61K 31/40 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil
A61K 31/407 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil condensés avec des systèmes hétérocycliques, p. ex. kétorolac, physostigmine
A61K 31/497 - Pyrazines non condensées contenant d'autres hétérocycles
7.
Methods of preparing and using placental tissue compositions
Methods of preparing placental tissue products/compositions are disclosed together with methods of utilizing the placental tissue composition for delivery of a therapeutic agent.
A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
A liquid formulation comprising an acellular extract of placental tissue and a solvent that may prevent the onset or reduce the symptoms of an intestinal condition in a subject when a therapeutically effective amount of the liquid formulation is delivered to a gastric system of the subject.
Biological products are disclosed that have improved qualities relative to those that are currently available. Disclosed are compositions and methods for modulating cellular physiology and pathological processing using compositions that are derived from various placenta/villous chorion tissue.
Compositions and associated methods of preparing placental tissue products/compositions are disclosed together with methods of utilizing the placental tissue composition for delivery of a therapeutic agent.
A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
Compositions and associated methods of preparing placental tissue products/compositions are disclosed together with methods of utilizing the placental tissue composition for delivery of a therapeutic agent.
A61K 47/46 - Ingrédients de constitution indéterminée ou leurs produits de réaction, p. ex. peau, os, lait, fibre de coton, coquille d’œuf, fiel de bœuf ou extraits de plante
A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
Biological products are disclosed that have improved qualities relative to those that are currently available. Disclosed are compositions and methods for modulating cellular physiology and pathological processing using compositions that are derived from various placenta/villous chorion tissue.
Disclosed herein are methods of treating a condition affecting bone tissue, muscle tissue, or connective tissue using a placenta-derived composition comprising placental tissue and one or more protease inhibitors. Also disclosed herein are methods of treating an individual having a malady comprising arthritis, osteoporosis, or fibrosis with a placenta-derived composition. Further disclosed herein are methods of treating an individual having irradiation damage to bone, muscle, or connective tissue with a placenta-derived composition.
Biological products are disclosed that have improved qualities relative to those that are currently available. Disclosed are compositions and methods for modulating cellular physiology and pathological processing using compositions that are derived from various placenta/villous chorion tissue.
A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
A61P 19/02 - Médicaments pour le traitement des troubles du squelette des troubles articulaires, p. ex. arthrites, arthroses
C12N 5/073 - Cellules ou tissus embryonnairesCellules fœtales ou tissus fœtaux
brevets
